Ipilimumab vs Tacrolimus
Ipilimumab vs Tacrolimus: Overview
This comparison examines the pharmacological differences between Ipilimumab and Tacrolimus.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Tacrolimus: Calcineurin inhibitor binding FKBP12; suppresses IL-2 transcription.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Tacrolimus — 12 hours.
Chemical Properties
Molecular Formula: Tacrolimus — C44H69NO12.
Molecular Weight: Tacrolimus — 804.0180 g/mol.
Type: Ipilimumab — Antibody; Tacrolimus — Small molecule.